0001140361-12-014470.txt : 20120309
0001140361-12-014470.hdr.sgml : 20120309
20120309145611
ACCESSION NUMBER: 0001140361-12-014470
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506
FILED AS OF DATE: 20120309
DATE AS OF CHANGE: 20120309
EFFECTIVENESS DATE: 20120309
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Altheus Therapeutics Inc
CENTRAL INDEX KEY: 0001414163
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-174656
FILM NUMBER: 12680284
BUSINESS ADDRESS:
STREET 1: 755 Research Parkway
STREET 2: Suite 435
CITY: Oklahoma City
STATE: OK
ZIP: 73104
BUSINESS PHONE: (405) 319-8177
MAIL ADDRESS:
STREET 1: 755 Research Parkway
STREET 2: Suite 435
CITY: Oklahoma City
STATE: OK
ZIP: 73104
D
1
primary_doc.xml
X0704
D
LIVE
0001414163
Altheus Therapeutics Inc
755 RESEARCH PARKWAY
SUITE 435
OKLAHOMA CITY
OK
OKLAHOMA
73104
(405) 319-8177
DELAWARE
None
None
Corporation
true
Dennis
Schafer
755 Research Parkway
Suite 435
Oklahoma City
OK
OKLAHOMA
73104
Executive Officer
Director
Richard
F.
Harty, MD
755 Research Parkway
Suite 435
Oklahoma City
OK
OKLAHOMA
73104
Executive Officer
Promoter
Brian
L.
Clevinger
c/o Prolog Ventures, LLC
7733 Forsyth Blvd., Suite 1440
St. Louis
MO
MISSOURI
63105
Executive Officer
Director
William
Paiva
ONEOK Plaza
100 W. 5th St., Suite 705
Tulsa
OK
OKLAHOMA
74103
Director
Thomas
L.
Shoaf
Stifel Nicolaus Company, Inc.
One Financial Plaza, 501 N. Broadway
St. Louis
MO
MISSOURI
63102
Director
Douglas
A.
Branch
101 N. Robinson
Corporate Tower, 13th Floor
Oklahoma City
OK
OKLAHOMA
73102
Director
Biotechnology
No Revenues
- 06
false
2012-02-24
false
true
false
967
7734919
5325851
2409068
The Total Amount Sold includes cash and notes that converted into the Series B shares sold hereunder. The Total Remaining to be Sold includes cash to be raised at the closing of a second tranche and an allowance for amounts sold to additional investors.
false
12
0
0
200000
true
Includes legal fees paid to a law firm affiliated with a director of the Company and deferred payments owed to certain of the Companies executive officers and directors.
false
Altheus Therapeutics Inc
Douglas A. Branch
Douglas A. Branch
Secretary
2012-03-09